JPWO2023049887A5 - - Google Patents

Info

Publication number
JPWO2023049887A5
JPWO2023049887A5 JP2024518884A JP2024518884A JPWO2023049887A5 JP WO2023049887 A5 JPWO2023049887 A5 JP WO2023049887A5 JP 2024518884 A JP2024518884 A JP 2024518884A JP 2024518884 A JP2024518884 A JP 2024518884A JP WO2023049887 A5 JPWO2023049887 A5 JP WO2023049887A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
substituted
unsubstituted
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536869A (ja
JP2024536869A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077001 external-priority patent/WO2023049887A1/en
Publication of JP2024536869A publication Critical patent/JP2024536869A/ja
Publication of JPWO2023049887A5 publication Critical patent/JPWO2023049887A5/ja
Publication of JP2024536869A5 publication Critical patent/JP2024536869A5/ja
Pending legal-status Critical Current

Links

JP2024518884A 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物 Pending JP2024536869A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163248566P 2021-09-27 2021-09-27
US63/248,566 2021-09-27
US202163273422P 2021-10-29 2021-10-29
US63/273,422 2021-10-29
US202263367546P 2022-07-01 2022-07-01
US63/367,546 2022-07-01
PCT/US2022/077001 WO2023049887A1 (en) 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2024536869A JP2024536869A (ja) 2024-10-08
JPWO2023049887A5 true JPWO2023049887A5 (https=) 2025-09-19
JP2024536869A5 JP2024536869A5 (https=) 2025-09-19

Family

ID=83692741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518884A Pending JP2024536869A (ja) 2021-09-27 2022-09-26 イミダゾピリダジンil-17阻害剤化合物

Country Status (16)

Country Link
US (2) US12173007B2 (https=)
EP (1) EP4408847A1 (https=)
JP (1) JP2024536869A (https=)
KR (1) KR20240082369A (https=)
AU (1) AU2022349687A1 (https=)
CA (1) CA3233408A1 (https=)
CL (1) CL2024000867A1 (https=)
CO (1) CO2024003723A2 (https=)
DO (1) DOP2024000051A (https=)
IL (1) IL311751A (https=)
JO (1) JOP20240059A1 (https=)
MX (1) MX2024003772A (https=)
PE (1) PE20240935A1 (https=)
TW (1) TW202330530A (https=)
UY (1) UY39958A (https=)
WO (1) WO2023049887A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024536869A (ja) 2021-09-27 2024-10-08 ヤンセン ファーマシューティカ エヌ.ベー. イミダゾピリダジンil-17阻害剤化合物
AU2022375634A1 (en) 2021-10-25 2024-06-06 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024163365A1 (en) * 2023-01-30 2024-08-08 Dice Alpha, Inc. Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
CN121311483A (zh) * 2023-03-28 2026-01-09 詹森药业有限公司 含内酰胺的咪唑并哒嗪il-17抑制剂化合物
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
KR20250168657A (ko) * 2023-04-11 2025-12-02 다이스 알파, 인크. 치환된 6-이미다조피리다진 il-17a 조정제 및 그의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
KR20230019507A (ko) 2020-04-30 2023-02-08 얀센 파마슈티카 엔.브이. Il-17의 조절제로서의 이미다조피리다진
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
JP2024536869A (ja) 2021-09-27 2024-10-08 ヤンセン ファーマシューティカ エヌ.ベー. イミダゾピリダジンil-17阻害剤化合物
CN116143777A (zh) 2021-11-04 2023-05-23 四川海思科制药有限公司 一种可抑制il-17a的杂环化合物及其用途

Similar Documents

Publication Publication Date Title
JP2018520161A5 (https=)
AU2021414253B2 (en) Series of piperidine-substituted benzoic acid compounds, and use thereof
JP2024050527A5 (https=)
JP2016147858A5 (https=)
JPWO2021222404A5 (https=)
HRP20190853T1 (hr) Cot modulatori i postupci za njihovu upotrebu
JP2023106403A5 (https=)
IL311751A (en) IL-17 imidazopyridazine inhibitory compounds
JPWO2021092115A5 (https=)
HRP20100020T1 (hr) Novi derivati hidantoina za liječenje opstruktivnih bolesti dišnih putova
JP2018519302A5 (https=)
JPWO2023049887A5 (https=)
JPH0314028B2 (https=)
JP2021522262A5 (https=)
JP2019515924A5 (https=)
JP2017534591A5 (https=)
JP2020530490A5 (https=)
JP2021528405A5 (https=)
KR20220127900A (ko) Jak 키나아제 관련 질병의 치료를 위한 약물의 제조에 있어서 jak 억제제의 용도
JPWO2023049886A5 (https=)
JP2691679B2 (ja) オキシム誘導体およびそれを含有する医薬品
JP2007500676A5 (https=)
JPS5921636A (ja) 新規カルバシクリン誘導体及びその製法
WO2022037680A1 (zh) 硼酸类化合物
JPWO2021207530A5 (https=)